When Does Private Equity Ownership of Physician Practices Violate "First, Do No Harm"?

Area of Science:

• Healthcare Management
• Medical Ethics
• Health Economics

Background:

• The increasing corporatization of medicine is significantly driven by private equity (PE) investments in physician practices.
• This trend raises concerns about the potential impact on the quality of healthcare delivery and patient well-being.

Purpose of the Study:

• To identify circumstances where private equity ownership negatively affects healthcare operations and patient outcomes.
• To analyze how these negative impacts can breach the ethical principle of 'primum non nocere' (first, do no harm).
• To propose strategies for reconciling the commercial interests of healthcare with its role as a fundamental human right.

Main Methods:

• Review of literature on private equity in healthcare.
• Analysis of case studies and ethical frameworks.
• Discussion of policy implications and potential regulatory approaches.

Main Results:

• Private equity involvement can lead to operational changes that compromise patient care and ethical standards.
• Specific investment models and profit-driven motives can conflict with the physician's duty to prioritize patient welfare.
• Evidence suggests a potential for patient harm when financial interests supersede clinical judgment.

Conclusions:

• The integration of private equity in healthcare necessitates careful ethical oversight to prevent harm.
• Balancing financial viability with the ethical imperative of patient well-being is crucial.
• Policy and regulatory frameworks are needed to ensure healthcare remains a right, not solely a commercial commodity.